These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1713912

  • 21. Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues.
    Padró T, van den Hoogen CM, Emeis JJ.
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):601-8. PubMed ID: 2133239
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Binding of tissue-type plasminogen activator to human melanoma cells.
    Bizik J, Stephens RW, Grofova M, Vaheri A.
    J Cell Biochem; 1993 Mar; 51(3):326-35. PubMed ID: 8501135
    [Abstract] [Full Text] [Related]

  • 24. A sensitive ELISA for human tissue-type plasminogen activator applicable to the study of acute release from cultured human endothelial cells.
    Schrauwen Y, Emeis JJ, Kooistra T.
    Thromb Haemost; 1994 Feb; 71(2):225-9. PubMed ID: 8191403
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
    Urdén G, Johansson U, Chmielewska J, Brandt J, Wiman B.
    Thromb Haemost; 1986 Jun 30; 55(3):383-7. PubMed ID: 3092395
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 30; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 33. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Kaneko M, Sakata Y, Matsuda M, Mimuro J.
    J Biochem; 1992 Feb 30; 111(2):244-8. PubMed ID: 1314812
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Characterization of a panel of monoclonal antibodies against human tissue-type plasminogen activator.
    Reilly TM, Flint SK, McHugh BG, Wilsbach-Volcheck KM, Timmermans PB.
    Hybridoma; 1988 Apr 30; 7(2):177-84. PubMed ID: 3131235
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.
    Chmielewska J, Rånby M, Wiman B.
    Biochem J; 1988 Apr 15; 251(2):327-32. PubMed ID: 3135797
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.